Oroxin A Induces Autophagic Cell Death in Gastric Cancer Cells Through the MAPK/ERK/REDD1 Axis
Cell Biology International · 2025
DOI: 10.1002/cbin.70092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biology International, 2025. Verfasst von Linen Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Diges…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Autophagic Cell Death, MAP Kinase Signaling System, Transcription Factors. Die Arbeit nennt 43 Literaturangaben. Gefördert von: This study was supported by the Double-Thousand Plan of Jiangxi Province (No. jxsq2023201044) and National Natural Science Foundation of China (No. 82360119)..
Abstract (Originalsprache)
Gastric cancer (GC) is one of the most prevalent malignant tumors worldwide, with limited treatment efficacy and high drug resistance. Natural compounds offer promising therapeutic potential due to their multitarget and low‐toxicity profiles. This study aimed to explore the anticancer effects of Oroxin A (OA), a natural flavonoid, and its underlying mechanisms in gastric cancer. A series of in vitro assays and organoid models were used to assess OA's effects on cell viability, proliferation, and migration. Mechanistic investigations included RNA‐sequencing, Western blot analysis, immunofluorescence, and electron microscopy. OA significantly inhibited gastric cancer cell growth and migration while showing minimal toxicity to normal gastric epithelial cells. OA induced autophagic, rather than apoptotic, cell death. Mechanistically, OA activated the MAPK/ERK signaling pathway, upregulated REDD1, and inhibited mTOR signaling, leading to enhanced autophagy. REDD1 overexpression amplified this effect, whereas knockdown reversed it. OA induces autophagic cell death in gastric cancer cells via the MAPK/ERK/REDD1 pathway, providing a promising natural compound candidate for gastric cancer therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Jiangxi Provincial Key Laboratory of Digestive Diseases, Jiangxi Clinical Research Center for Gastroenterology, Digestive Disease Hospital, The First Affiliated Hospital, Jiangxi Medical…
- Postdoctoral Innovation Practice Base, The First Affiliated Hospital of Nanchang University, Nanchang, China.
ORCID-Profile: Xu Shu
Förderung
- This study was supported by the Double-Thousand Plan of Jiangxi Province (No. jxsq2023201044) and National Natural Science Foundation of China (No. 82360119).
Zitieren
APA
Li, L., Rong, J., Liao, F., Shangguan, J., Xie, C., Zhu, Y., & Shu, X. (2025). Oroxin A Induces Autophagic Cell Death in Gastric Cancer Cells Through the MAPK/ERK/REDD1 Axis. Cell Biology International. https://doi.org/10.1002/cbin.70092
Vancouver
Li L, Rong J, Liao F, Shangguan J, Xie C, Zhu Y, et al. Oroxin A Induces Autophagic Cell Death in Gastric Cancer Cells Through the MAPK/ERK/REDD1 Axis. Cell Biology International. 2025. doi:10.1002/cbin.70092
BibTeX
@article{Li2025,
author = {Li, Linen and Rong, Jianfang and Liao, Foqiang and Shangguan, Jianfang and Xie, Chuan and Zhu, Yin and Shu, Xu},
title = {Oroxin A Induces Autophagic Cell Death in Gastric Cancer Cells Through the MAPK/ERK/REDD1 Axis},
journal = {Cell Biology International},
year = {2025},
doi = {10.1002/cbin.70092}
}
EUVIMED